Product Program year 2025 Source: CMS Open Payments

Photrexa Viscous and Photrexa

Drug Ophthalmology

Open in the dashboard

General payments

$273,175

3,176 payments

Research payments

$2,701

2 payments

Through program year 2025, $273,175 in general payments and $2,701 in research payments were reported against Photrexa Viscous and Photrexa (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $273,175 3,176
2025 Research $2,701 2

Breakdown

Who paid General payments · program year 2025
  1. Glaukos Corporation $273,175 3,176 payments
Top recipients General payments · program year 2025
  1. University Of Miami Hospital Teaching hospital · FL $10,000 4% · 1 payment
  2. Kristin Bains Ophthalmology · Birmingham, AL $1,824 <1% · 24 payments
  3. William Lee Cornea and External Diseases Specialist · Atlanta, GA $1,347 <1% · 21 payments
  4. Priya Patel Ophthalmology · New York, NY $1,024 <1% · 13 payments
  5. Yun Bo Tian Cornea and External Diseases Specialist · Durham, NC $956 <1% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Optometrist $172,147 66% · 1,378 practitioners
  2. Ophthalmology $65,656 25% · 520 practitioners
  3. Cornea and External Diseases Specialist Ophthalmology $11,208 4% · 62 practitioners
  4. Optometrist, Corneal and Contact Management Optometrist $4,755 2% · 42 practitioners
  5. Glaucoma Specialist Ophthalmology $786 <1% · 11 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $42,387 16% · 322 recipients
  2. Florida $33,333 12% · 160 recipients
  3. Texas $32,122 12% · 234 recipients
  4. Georgia $16,160 6% · 114 recipients
  5. Illinois $13,981 5% · 107 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,176 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record